|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 33.50 CNY | +0.93% |
|
-3.10% | +14.14% |
| 05-11 | Chinese Drug Regulator Accepts Kelun Pharma's Supplemental Application for Jiataile | MT |
| 04-29 | Sichuan Kelun Pharmaceutical's Attributable Profit Falls 22% in Q1 | MT |
| Capitalization | 51.47B 7.58B 6.46B 5.93B 5.61B 10.4B 725B 10.5B 70.59B 27.49B 344B 28.43B 27.83B 1,195B | P/E ratio 2026 * |
26.2x | P/E ratio 2027 * | 21.3x |
|---|---|---|---|---|---|
| Enterprise value | 44.65B 6.57B 5.61B 5.14B 4.87B 9.02B 629B 9.11B 61.24B 23.85B 298B 24.67B 24.15B 1,037B | EV / Sales 2026 * |
2.19x | EV / Sales 2027 * | 1.99x |
| Free-Float |
67.24% | Yield 2026 * |
2.45% | Yield 2027 * | 2.35% |
Last Transcript: Sichuan Kelun Pharmaceutical Co., Ltd.
| 1 day | +0.93% | ||
| 1 week | -3.10% | ||
| Current month | -3.10% | ||
| 1 month | -1.47% | ||
| 3 months | +5.48% | ||
| 6 months | +1.12% | ||
| Current year | +14.14% |
| 1 week | 32.6 |  | 34.5 |
| 1 month | 32.51 | | 36.15 |
| Current year | 29.07 | | 36.9 |
| 1 year | 28.14 | | 41.72 |
| 3 years | 21.6 | | 41.72 |
| 5 years | 14.53 | | 41.72 |
| 10 years | 14.11 | | 41.72 |
| Manager | Title | Age | Since |
|---|---|---|---|
Si Chuan Liu
CEO | Chief Executive Officer | 42 | 2015-09-07 |
De Gui Lai
DFI | Director of Finance/CFO | 55 | 2014-10-22 |
Meng Ran Wang
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Ge Xin Liu
CHM | Chairman | 75 | 1995-12-31 |
Si Chuan Liu
BRD | Director/Board Member | 42 | 2009-06-25 |
Chang Yan Zheng
BRD | Director/Board Member | 52 | 2008-05-15 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +3.61% | 0% | 33,076 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.93% | -3.10% | +0.60% | +9.51% | 7.84B | |
| +2.37% | +0.10% | +31.01% | +127.85% | 883B | |
| +1.28% | -0.57% | +45.49% | +39.48% | 540B | |
| +2.51% | +0.85% | +9.36% | +41.26% | 367B | |
| +0.87% | -1.00% | +20.39% | +10.73% | 328B | |
| -1.08% | +0.35% | +33.73% | +13.45% | 288B | |
| +0.16% | +0.42% | +28.88% | +25.55% | 283B | |
| +0.98% | -0.69% | +39.71% | -4.07% | 278B | |
| +1.72% | +3.19% | -31.06% | -47.96% | 206B | |
| +2.03% | +2.03% | +22.39% | +44.36% | 181B | |
| Average | +0.41% | +0.81% | +20.05% | +26.02% | 336.16B | |
| Weighted average by Cap. | +0.33% | +0.60% | +26.36% | +47.91% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 20.35B 3B 2.56B 2.34B 2.22B 4.11B 287B 4.15B 27.92B 10.87B 136B 11.24B 11.01B 473B | 22.08B 3.25B 2.77B 2.54B 2.41B 4.46B 311B 4.5B 30.29B 11.8B 148B 12.2B 11.94B 513B |
| Net income | 2.04B 301M 257M 235M 223M 413M 28.79B 417M 2.8B 1.09B 13.65B 1.13B 1.1B 47.44B | 2.51B 369M 315M 289M 274M 507M 35.36B 512M 3.44B 1.34B 16.77B 1.39B 1.36B 58.28B |
| Net Debt | -6.82B -1B -856M -785M -743M -1.38B -96.07B -1.39B -9.35B -3.64B -45.57B -3.77B -3.69B -158B | -7.55B -1.11B -948M -869M -823M -1.53B -106B -1.54B -10.35B -4.03B -50.46B -4.17B -4.08B -175B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-05-12 | 33.50 ¥ | +0.93% | 18,029,670 |
| 26-05-11 | 33.19 ¥ | -1.34% | 16,088,680 |
| 26-05-08 | 33.64 ¥ | -1.15% | 9,327,655 |
| 26-05-07 | 34.03 ¥ | +0.06% | 13,794,110 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 002422 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition